Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):557-65.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.